You've never seen anything like it · Doors open inStarts at 7:00 PM ET
Skip to content

Research peptide · Other compounds research

Thyrotropin-releasing hormone

Also known as protirelin · TRH · pyroglutamyl-histidyl-prolinamide

A tripeptide amide, pyroglutamyl-histidyl-prolinamide, with both termini blocked. Molecular formula C16H22N6O4, average molecular weight 362.38 g/mol.

Compound type
Research peptide
Research area
Other compounds
Formula
C16H22N6O4
Average mass
362.384 Da
Monoisotopic mass
362.1703 Da
Length
3 residues
PubChem
CID 638678

What it is

Thyrotropin-releasing hormone is a tripeptide amide with the structure pyroglutamyl-histidyl-prolinamide. Its molecular formula is C16H22N6O4, its average molecular weight is 362.38 g/mol and its monoisotopic mass is 362.17. PubChem indexes it under CID 638678 with the title protirelin, which is the formal name for the synthetic material.

It is a hypothalamic releasing factor: the signal that acts on the anterior pituitary to release thyrotropin, which in turn acts on the thyroid, and it also stimulates release of prolactin. Its receptors are members of the class A G protein-coupled receptor family.

Discovery and origin

The structure was established in 1969 by two groups working in parallel. One demonstrated the pyroglutamyl-histidyl-prolinamide sequence in material of ovine origin by mass spectrometry 1. The other showed that synthetic pyroglutamyl-histidyl-proline amide has the same chemical and hormonal properties as the hypothalamic factor isolated from tissue 2. Identification of this tripeptide is one of the founding results of hypothalamic releasing-factor chemistry, reached after processing very large quantities of hypothalamic tissue to obtain workable amounts of material.

Structure and chemistry

Both ends of the molecule are blocked, which is the chemically interesting feature. The N terminus is a pyroglutamate, the cyclized lactam formed from glutamine or glutamate, so there is no free alpha-amino group, and the C terminus is a prolinamide rather than a free carboxylate. A blocked tripeptide of this kind gives no reaction with reagents that detect free amines, which is worth knowing before a colorimetric assay is chosen.

The only ionizable group of consequence is the histidine imidazole, with a pKa near neutrality, so the molecule shifts between neutral and singly protonated across ordinary buffer conditions. It is small, highly polar and freely soluble in water. There is no cysteine and no strongly absorbing aromatic residue, so ultraviolet detection is weak and sits at low wavelength.

Analytical notes

Identity is confirmed by liquid chromatography coupled to mass spectrometry in positive ion mode, with the expected singly protonated ion near m/z 363.18. At this mass the average and monoisotopic calculations differ by about 0.2, which is small relative to typical tolerances but worth noting on a certificate.

Purity is assessed by reversed-phase HPLC, where the absence of a chromophore forces detection near 214 nm and the very polar tripeptide is weakly retained on standard C18 columns; ion pairing, an aqueous-compatible stationary phase or HILIC are the usual answers. The impurities worth resolving are the free-acid form from hydrolysis of the C-terminal amide, the uncyclized glutaminyl precursor and diastereomers from epimerization. Fragmentation in tandem mass spectrometry is limited for a blocked tripeptide, so retention time against a reference standard is more informative than usual.

Storage and handling in the laboratory

As supplied, the material is a lyophilized powder, stored at -20 degrees Celsius, sealed and protected from light and moisture. Hydrolysis of the C-terminal amide is the degradation route to watch in solution, and it is accelerated at extremes of pH, so near-neutral buffers and fresh solutions are preferable for quantitative work.

Open questions in the literature

Published laboratory work on the tripeptide itself is largely historical, concentrated in the period when its structure was being settled, and modern physicochemical characterization is sparse: solution stability under common assay conditions and the behavior of the pyroglutamate cap are not well documented in accessible sources. Receptor-level work is mostly conducted on the receptors rather than on the ligand.

Identity check

A mass-spectrometry result for Thyrotropin-releasing hormone (TRH) should show peaks near these values. A result more than about one unit away is worth a question to the testing lab. Salt forms such as acetate or TFA do not move these peaks, though they do mean less peptide in each milligram of powder.

IonExpected m/z
[M+H]+363.18

References

  1. Burgus R, Dunn TF, Desiderio D, Guillemin R. [Molecular structure of the hypothalamic hypophysiotropic TRF factor of ovine origin: mass spectrometry demonstration of the PCA-His-Pro-NH2 sequence]. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, Serie D. 1969;269(19):1870-1873. Source
  2. Boler J, Enzmann F, Folkers K, Bowers CY, Schally AV. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochemical and Biophysical Research Communications. 1969;37(4):705-710. doi:10.1016/0006-291x(69)90868-7. Source

For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.